Live feed
Filing
SCHEDULE 13G/A
SCHEDULE 13G/A0001231919-26-000157·Frazier Life Sciences Public Fund, L.P.
Schedule 13G ownership disclosure
MEREO BIOPHARMA GROUP PLC
Ordinary Shares, nominal value EURO0.003 per share, represented by American Depository Shares · CUSIP: 589492107
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Frazier Life Sciences Public Fund, L.P.
Shares: 0.00 · Class: 0.0%
- FHMLSP, L.P.
Shares: 0.00 · Class: 0.0%
- FHMLSP, L.L.C.
Shares: 0.00 · Class: 0.0%
- Frazier Life Sciences X, L.P.
Shares: 0.00 · Class: 0.0%
- FHMLS X, L.P.
Shares: 0.00 · Class: 0.0%
- FHMLS X, L.L.C.
Shares: 0.00 · Class: 0.0%
- Frazier Life Sciences XI, L.P.
Shares: 0.00 · Class: 0.0%
- FHMLS XI, L.P.
Shares: 0.00 · Class: 0.0%
- FHMLS XI, L.L.C.
Shares: 0.00 · Class: 0.0%
- James N. Topper
Shares: 0.00 · Class: 0.0%
- Patrick J. Heron
Shares: 0.00 · Class: 0.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001231919-26-000157
- Form type
- SCHEDULE 13G/A
- Filer
- Frazier Life Sciences Public Fund, L.P.
- CIK
- CIK 1863769
- Filed
- Feb 13, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership